Benzethonium chloride is a synthetic antimicrobial compound that belongs to a family of chemicals called quaternary ammonium compounds, or “quats.” It has been used since the mid-twentieth century in products ranging from hand sanitizers and first-aid antiseptics to cosmetics and vaccine preservatives. Its regulatory story, though, has taken some sharp turns in recent years, and understanding what the compound actually does and where it stands with the FDA requires sorting through a fair amount of nuance.
The Basics of Benzethonium Chloride
Benzethonium chloride (often abbreviated BZT or BEC) is a white, odorless crystalline powder that dissolves easily in water and alcohol. It carries a positive electrical charge, which is part of what makes it effective against microbes: bacterial cell membranes are negatively charged, so the compound is attracted to them, disrupts their structure, and causes cells to leak and die. This broad-spectrum activity means it works against a wide range of bacteria and some fungi, though like most quats it is not effective against bacterial spores.
You will find benzethonium chloride listed on the ingredient labels of first-aid antiseptic sprays, medicated towelettes, cosmetic preservatives, deodorants, and some over-the-counter skin treatments. It also serves as a preservative in certain pharmaceutical products, including the U.S. anthrax vaccine, where an accurate analytical method can detect it at concentrations as low as 0.5 parts per million.
How Well Does It Kill Germs?
Benzethonium chloride’s germ-killing ability has been tested both in the lab and on human hands. In a clinical study comparing a benzethonium chloride hand sanitizer to a standard alcohol-based sanitizer, the two performed similarly. After a single application on hands contaminated with E. coli, the benzethonium chloride formula reduced bacterial counts by roughly the same amount as the alcohol product. After five applications, the two remained statistically equivalent, with the benzethonium chloride formulation producing slightly higher average reductions.
That result matters because alcohol-based sanitizers are widely regarded as the gold standard for hand hygiene outside of soap and water. The fact that a non-alcohol alternative could match that performance gave benzethonium chloride a practical niche, especially in products designed for people who find alcohol sanitizers drying or irritating to the skin.
FDA Status and the 2016 Regulatory Shift
For decades, benzethonium chloride was used as an active ingredient in over-the-counter consumer antiseptic wash products, including antibacterial hand soaps and body washes. That changed substantially in 2016, when the FDA issued a final rule determining that benzethonium chloride, along with several other antimicrobial ingredients like triclosan and triclocarban, was not generally recognized as safe and effective (GRAS/GRAE) for use in OTC consumer antiseptic wash products. Manufacturers could no longer market consumer hand soaps or body washes with benzethonium chloride as an active ingredient unless they obtained new drug approval.
The FDA’s reasoning was not that benzethonium chloride had been shown to be dangerous. Rather, the agency concluded that manufacturers had not provided sufficient data to demonstrate that these ingredients were both safe for long-term daily use and more effective than plain soap and water. The bar the FDA set was straightforward: if you are going to put an antimicrobial chemical in a consumer wash product, you need to prove it adds a meaningful benefit over regular soap, and you need to show that daily exposure over months or years does not carry risks. The data submitted did not clear that bar.
This rule applied specifically to consumer antiseptic wash products, the kind you rinse off. It did not cover all uses of benzethonium chloride. The compound can still be found in:
- First-aid antiseptics: products applied to minor cuts and scrapes, which fall under a separate FDA monograph
- Healthcare antiseptics: products used in clinical settings, which are regulated differently
- Cosmetic preservatives: where benzethonium chloride is used at low concentrations to prevent microbial growth in the product itself, not as an active antimicrobial claim
- Pharmaceutical preservatives: including its use in certain injectable vaccines and drug formulations
The practical upshot is that benzethonium chloride largely disappeared from the consumer antibacterial soap aisle but remains present in first-aid sprays, certain leave-on products, and pharmaceutical applications. If you see it on a product label today, the product is either using it as a preservative rather than an active antiseptic, or it falls into a category the 2016 rule did not cover.
Safety on the Skin
Benzethonium chloride is generally well tolerated at the concentrations found in consumer products, but it is not entirely without risk. Like other quaternary ammonium compounds, it has been identified as a potential cause of contact dermatitis in some people. A review of quaternary ammonium compounds and skin sensitivity noted that benzethonium chloride, along with related compounds like benzalkonium chloride and cetrimonium bromide, can trigger allergic skin reactions in susceptible individuals.
In clinical patch testing, researchers have observed both irritant and genuinely allergic reactions to benzethonium chloride. One study using patch tests at various concentrations found that while most subjects tolerated the compound well, two patients showed definite allergic reactions that were clinically relevant, and one of those patients also cross-reacted with benzalkonium chloride, a closely related quat commonly found in eye drops and nasal sprays. Cross-reactivity between quats is a known phenomenon and something worth mentioning to a dermatologist if you have had a reaction to one member of the family.
For cosmetic products applied around the eyes, safety assessments have concluded that a maximum concentration of 0.02 percent benzethonium chloride is safe. Products used elsewhere on the body generally contain somewhat higher concentrations, typically in the range of 0.1 to 0.5 percent depending on the application. These limits were established through the Cosmetic Ingredient Review process, which evaluates safety data for ingredients used in personal care products.
Does It Drive Antibiotic Resistance?
One of the bigger concerns around antimicrobial chemicals in consumer products is whether widespread use could contribute to antibiotic resistance. For benzalkonium chloride, the more widely used cousin of benzethonium chloride, there is a substantial body of research on this question, and the picture is complex. For benzethonium chloride specifically, the evidence base is much thinner.
A review of the available literature found only six peer-reviewed studies examining benzethonium chloride and bacterial resistance. Among those, only one directly tested whether exposing bacteria to benzethonium chloride changed their susceptibility to antibiotics. That study managed to produce stable bacterial mutants with increased tolerance to benzethonium chloride itself through repeated exposure, but found no change in antibiotic susceptibility. Another study noted that exposure to benzethonium chloride upregulated certain efflux pump genes in Listeria monocytogenes, a food-safety pathogen, but did not provide susceptibility data to show whether that gene activity translated into actual resistance. The review concluded that the limited data on benzethonium chloride do not allow a firm conclusion that it drives antibiotic resistance in real-world conditions.
That finding is reassuring as far as it goes, but “insufficient evidence to conclude a problem exists” is not the same as “evidence that no problem exists.” The research gap itself is the story here. Benzalkonium chloride, used in far more products, has attracted much more scrutiny and generated some concerning laboratory findings around resistance selection. Benzethonium chloride simply has not been studied enough to know whether it behaves the same way.
Environmental Concerns
Because benzethonium chloride washes down drains and enters wastewater, researchers have begun examining what it does to aquatic organisms. A study on Daphnia carinata, a small freshwater crustacean commonly used as a sentinel species for water quality, measured the concentrations at which benzethonium chloride becomes lethal. The 48-hour concentration required to kill half the test organisms was about 0.26 milligrams per liter, dropping to roughly 0.16 milligrams per liter over 96 hours. Those are fairly low thresholds, suggesting that benzethonium chloride is quite toxic to this type of aquatic invertebrate.
More concerning, the same study tracked effects across two generations and found that offspring of exposed organisms showed both resistance to the compound and higher sensitivity to its sublethal effects. In plain terms, the organisms that survived benzethonium chloride exposure produced offspring that could tolerate higher concentrations without dying, but those offspring showed more problems at lower, non-lethal doses. That kind of multigenerational toxicity pattern raises questions about what chronic low-level contamination could do in real waterways, although translating lab findings on tiny crustaceans directly to environmental policy is always a stretch.
Unexpected Pharmacological Activity
One of the more surprising findings about benzethonium chloride is that it appears to be pharmacologically active in ways that go well beyond simple germ killing. A study examining benzethonium chloride as a preservative in ketamine formulations found that the compound binds to numerous receptors and transporters in the brain. It showed particularly strong affinity for the sigma-2 receptor and also bound to the dopamine transporter, among others. In mouse brain tissue, it enhanced synaptic signaling at remarkably low concentrations.
The implications are not yet clear, but the researchers raised the possibility that benzethonium chloride, present as a supposedly inert preservative in ketamine drug products, could contribute to some of the clinical effects observed with ketamine treatment. This is an early finding and should not be overinterpreted, but it challenges the assumption that benzethonium chloride is pharmacologically inactive when used as an excipient. It is a useful reminder that “preservative” does not automatically mean “biologically inert.”
Early-Stage Cancer Research
In a separate line of investigation, benzethonium chloride was identified through a cell-based screening as a compound with potential anticancer activity. Researchers tested it against various cell lines, including head-and-neck cancer cells and nasopharyngeal cancer cells, and found that it could reduce the viability of cancer cells at relatively low concentrations. Normal fibroblast cells required higher concentrations to be affected, suggesting some degree of selectivity.
This research is firmly in the early preclinical stage. No human trials have been conducted, and a compound that kills cancer cells in a dish does not necessarily translate into a useful drug. Many substances are toxic to cells in culture without being practical cancer treatments. Still, the finding is noteworthy because benzethonium chloride has decades of human safety data at low concentrations, which could theoretically shorten the path to clinical testing if the anticancer activity holds up in animal models.
The Grapefruit Seed Extract Controversy
Benzethonium chloride played a starring role in one of the more colorful controversies in the supplement world. Grapefruit seed extract (GSE) has been marketed for years as a natural antimicrobial, with enthusiastic claims about its ability to kill bacteria and fungi. Multiple laboratory analyses, however, found that the antimicrobial activity of commercial GSE products was not coming from grapefruit at all. Researchers who developed analytical methods to test these products detected benzethonium chloride, along with other synthetic preservatives like methylparaben and triclosan, as undeclared ingredients in products sold as pure grapefruit seed extract.
The amounts were not trivial. The synthetic antimicrobials were present at levels sufficient to explain the germ-killing properties attributed to the “natural” extract. When researchers tested grapefruit seed extract that had been prepared in the lab without any synthetic additives, it showed no meaningful antimicrobial activity. The implication was clear: the product’s reputation as a natural antimicrobial was built on the back of unlabeled synthetic chemicals, benzethonium chloride chief among them.
Benzethonium Chloride in Vaccines
Benzethonium chloride serves as a preservative in the U.S. licensed anthrax vaccine (Anthrax Vaccine Adsorbed, or AVA). In this role, it prevents microbial contamination of multi-dose vials. The concentration used is very low, and an HPLC-based analytical method was developed specifically to measure benzethonium chloride in the anthrax vaccine with high precision, achieving recovery rates of about 100 percent and able to detect the compound down to 0.5 parts per million.
The use of benzethonium chloride in vaccines has occasionally generated questions from people concerned about injectable preservatives. The amounts involved are extremely small, and the compound has a long track record in this application. It is worth noting that the concerns people tend to raise about vaccine preservatives often conflate different chemicals. Benzethonium chloride is not thimerosal (the mercury-containing preservative that generated extensive public debate), and it functions through an entirely different mechanism. Its inclusion in the anthrax vaccine has not been associated with safety signals in post-marketing surveillance.
How Benzethonium Chloride Compares to Related Compounds
Benzethonium chloride is one of several quaternary ammonium compounds used as antimicrobials, and it helps to understand where it sits in the family. Benzalkonium chloride, its more widely used relative, is found in an enormous range of products from eye drops to surface disinfectants to nasal sprays. Both share the same basic mechanism of action: they carry a positive charge that disrupts negatively charged bacterial membranes. Both have broad-spectrum activity and both are ineffective against bacterial spores.
The practical differences come down to usage patterns and regulatory treatment. Benzalkonium chloride has been studied far more extensively, for better and worse. There is more evidence supporting its effectiveness, but also more evidence raising concerns about resistance selection and skin sensitization. Benzethonium chloride has a smaller research footprint, which means fewer documented problems but also less certainty about long-term effects. Chloroxylenol, another antiseptic active ingredient found in some consumer products, works through a different chemical mechanism but faces similar regulatory uncertainty regarding its long-term safety and added benefit over plain soap.
For a consumer trying to make sense of ingredient labels, the most useful takeaway is that all of these compounds are effective antimicrobials when used properly, and none of them have been shown to provide meaningful additional benefit in consumer hand-washing products compared to thorough washing with regular soap and water. Their value lies more in specific applications: first-aid treatment, healthcare settings, product preservation, and situations where soap and water are not available.